Fisher Funds Management LTD

Position in BSX — Boston Scientific Corp

CIK 1435028 AUCKLAND, Q2

Position in BSX

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$43,015,635

-$11,009,856 QoQ

Shares Held

1,007,864

+17.1% QoQ

Ownership

0.070%

of shares outstanding

% of Portfolio

1.24%

of 13F equity value

Holder Rank

#148

of 1,468 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Fisher Funds Management LTD holds $144,868,330 across 5 Medical Devices names. BSX ranks #2 (29.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	DXCM	Dexcom Inc	840,950	$56,637,982
2	BSX	Boston Scientific Corp This page	1,007,864	$43,015,635
3	EW	Edwards Lifesciences Corp	397,646	$35,971,057
4	ABT	Abbott Laboratories	59,326	$5,383,241
5	MDT	Medtronic plc	49,347	$3,860,415

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$43,015,635	1,007,864	+17.1%	Shares	Sole	2026-07-14
2026-03-31	$54,025,491	860,964	+132.3%	Shares	Sole	2026-04-16
2025-12-31	$35,334,516	370,577	-23.3%	Shares	Sole	2026-01-26
2025-09-30	$47,176,378	483,216	-49.1%	Shares	Sole	2025-10-29
2025-06-30	$101,942,186	949,094	-10.6%	Shares	Sole	2025-08-04
2025-03-31	$107,123,664	1,061,892	0.0%	Shares	Sole	2025-04-29
2024-12-31	$94,848,193	1,061,892	—	Shares	Sole	2025-02-04
No filing history on record for this holder in this stock.